The State of Maryland and 58 of its 60 qualifying subdivisions have elected to participate in opioid medication settlement agreements with opioids manufacturer Johnson & Johnson and three major opioids…
Despite continuing focus on the COVID-19 pandemic, public health officials remain concerned with opioid overdose and overdose-related death. The Centers for Disease Control and Prevention (CDC) recently released data indicating…
At this year's Winter MACo Conference, the Attorney General was joined by several local government representatives to discuss Maryland's settlement with Johnson and Johnson and three major distributors of opioid…
On June 30th, the U.S. Food and Drug Administration (FDA), working jointly with the Federal Trade Commission (FTC), issued warning letters to companies selling kratom products to treat or cure opioid…
On Friday, November 5th, MACo submitted the names of seven county officials to the Maryland Attorney General's Office to participate in the Johnson and Johnson opioid settlement workgroup. The workgroup…
The pending multi-governmental settlement with opioid manufacturer Johnson & Johnson and three major medical distributors has been delayed. Maryland counties will have until January 26 (previously January 2) to decide…
After months of discussion, the Attorney General's Office, alongside a workgroup of MACo and Maryland Municipal League representatives, submitted a revised memorandum of understanding (MOU) to county leadership regarding the…
This week, Baltimore County Executive Johnny Olszewski announced a new data dashboard to provide detailed information about fatal and nonfatal opioid overdose incidents occurring in Baltimore County. The Opioid Overdose…
© 2019 All rights reserved
